These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33343564)

  • 1. Differential Skewing of Circulating MR1-Restricted and γδ T Cells in Human Psoriasis Vulgaris.
    Plužarić V; Štefanić M; Mihalj M; Tolušić Levak M; Muršić I; Glavaš-Obrovac L; Petrek M; Balogh P; Tokić S
    Front Immunol; 2020; 11():572924. PubMed ID: 33343564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of the antigen-presenting molecule MR1 by a Vδ3
    Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human liver CD8
    Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
    J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the TCRβ repertoire of peripheral MR1-restricted MAIT cells in psoriasis vulgaris patients.
    Jirouš Drulak M; Grgić Z; Plužarić V; Šola M; Opačak-Bernardi T; Viljetić B; Glavaš K; Tolušić-Levak M; Periša V; Mihalj M; Štefanić M; Tokić S
    Sci Rep; 2023 Nov; 13(1):20990. PubMed ID: 38017021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human blood MAIT cell subsets defined using MR1 tetramers.
    Gherardin NA; Souter MN; Koay HF; Mangas KM; Seemann T; Stinear TP; Eckle SB; Berzins SP; d'Udekem Y; Konstantinov IE; Fairlie DP; Ritchie DS; Neeson PJ; Pellicci DG; Uldrich AP; McCluskey J; Godfrey DI
    Immunol Cell Biol; 2018 May; 96(5):507-525. PubMed ID: 29437263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAIT cell-MR1 reactivity is highly conserved across multiple divergent species.
    Edmans MD; Connelley TK; Morgan S; Pediongco TJ; Jayaraman S; Juno JA; Meehan BS; Dewar PM; Maze EA; Roos EO; Paudyal B; Mak JYW; Liu L; Fairlie DP; Wang H; Corbett AJ; McCluskey J; Benedictus L; Tchilian E; Klenerman P; Eckle SBG
    J Biol Chem; 2024 Jun; 300(6):107338. PubMed ID: 38705391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miR-20a/miR-92b Profile Is Associated with Circulating γδ T-Cell Perturbations in Mild Psoriasis.
    Tokić S; Jirouš M; Plužarić V; Mihalj M; Šola M; Tolušić Levak M; Glavaš K; Balogh P; Štefanić M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation.
    Suliman S; Kjer-Nielsen L; Iwany SK; Lopez Tamara K; Loh L; Grzelak L; Kedzierska K; Ocampo TA; Corbett AJ; McCluskey J; Rossjohn J; León SR; Calderon R; Lecca-Garcia L; Murray MB; Moody DB; Van Rhijn I
    J Immunol; 2022 Mar; 208(6):1389-1395. PubMed ID: 35246495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR1-restricted mucosal-associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in nonhuman primates.
    Greene JM; Dash P; Roy S; McMurtrey C; Awad W; Reed JS; Hammond KB; Abdulhaqq S; Wu HL; Burwitz BJ; Roth BF; Morrow DW; Ford JC; Xu G; Bae JY; Crank H; Legasse AW; Dang TH; Greenaway HY; Kurniawan M; Gold MC; Harriff MJ; Lewinsohn DA; Park BS; Axthelm MK; Stanton JJ; Hansen SG; Picker LJ; Venturi V; Hildebrand W; Thomas PG; Lewinsohn DM; Adams EJ; Sacha JB
    Mucosal Immunol; 2017 May; 10(3):802-813. PubMed ID: 27759023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR1-Restricted T Cells Are Unprecedented Cancer Fighters.
    Vacchini A; Chancellor A; Spagnuolo J; Mori L; De Libero G
    Front Immunol; 2020; 11():751. PubMed ID: 32411144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique and Common Features of Innate-Like Human Vδ2
    Provine NM; Binder B; FitzPatrick MEB; Schuch A; Garner LC; Williamson KD; van Wilgenburg B; Thimme R; Klenerman P; Hofmann M
    Front Immunol; 2018; 9():756. PubMed ID: 29740432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1.
    Yan J; Allen S; McDonald E; Das I; Mak JYW; Liu L; Fairlie DP; Meehan BS; Chen Z; Corbett AJ; Varelias A; Smyth MJ; Teng MWL
    Cancer Discov; 2020 Jan; 10(1):124-141. PubMed ID: 31826876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis.
    Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S
    Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU).
    Li K; Vorkas CK; Chaudhry A; Bell DL; Willis RA; Rudensky A; Altman JD; Glickman MS; Aubé J
    PLoS One; 2018; 13(2):e0191837. PubMed ID: 29401462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
    Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
    Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
    Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
    Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells.
    Ussher JE; van Wilgenburg B; Hannaway RF; Ruustal K; Phalora P; Kurioka A; Hansen TH; Willberg CB; Phillips RE; Klenerman P
    Eur J Immunol; 2016 Jul; 46(7):1600-14. PubMed ID: 27105778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of MR1 ligand glyco-analogues on mucosal-associated invariant T (MAIT) cell activation.
    Braganza CD; Shibata K; Fujiwara A; Motozono C; Sonoda KH; Yamasaki S; Stocker BL; Timmer MSM
    Org Biomol Chem; 2019 Oct; 17(40):8992-9000. PubMed ID: 31497838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR1-restricted T cells: the new dawn of cancer immunotherapy.
    Wang Z; Wang M; Chen J; Zhang L; Zhang L; Yu L
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells.
    Reantragoon R; Corbett AJ; Sakala IG; Gherardin NA; Furness JB; Chen Z; Eckle SB; Uldrich AP; Birkinshaw RW; Patel O; Kostenko L; Meehan B; Kedzierska K; Liu L; Fairlie DP; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J; Kjer-Nielsen L
    J Exp Med; 2013 Oct; 210(11):2305-20. PubMed ID: 24101382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.